rezolutebio.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Home - Rezolute
Description Our Virtual Kol Event: RZ402 - An Oral Plasma Kallikrein Inhibitor for DME - Wednesday, March 22, 2023 at 4:30 PM Edt Learn More » --> Investors & Me
Keywords N/A
Server Information
WebSite rezolutebio faviconrezolutebio.com
Host IP 174.129.30.187
Location United States
Related Websites
Site Rank
More to Explore
rezolutebio.com Valuation
US$8,458,321
Last updated: 2023-04-29 10:43:31

rezolutebio.com has Semrush global rank of 1,251,348. rezolutebio.com has an estimated worth of US$ 8,458,321, based on its estimated Ads revenue. rezolutebio.com receives approximately 975,961 unique visitors each day. Its web server is located in United States, with IP address 174.129.30.187. According to SiteAdvisor, rezolutebio.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$8,458,321
Daily Ads Revenue US$7,808
Monthly Ads Revenue US$234,231
Yearly Ads Revenue US$2,810,766
Daily Unique Visitors 65,065
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
rezolutebio.com. A 600 IP: 174.129.30.187
rezolutebio.com. A 600 IP: 54.208.101.55
rezolutebio.com. NS 3600 NS Record: ns03.domaincontrol.com.
rezolutebio.com. NS 3600 NS Record: ns04.domaincontrol.com.
rezolutebio.com. MX 3600 MX Record: 0 rezolutebio-com.mail.protection.outlook.com.
rezolutebio.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-04-29 10:43:31
Virtual Kol Event: RZ402 - An Oral Plasma Kallikrein Inhibitor for DME - Wednesday, March 22, 2023 at 4:30 PM Edt Learn More » --> Investors & Media Overview Corporate Presentation News & Events Stock Quote and Chart Historical Data Analyst Coverage SEC Filings Governance Info Contact Us Therapeutic Focus Pipeline RZ358 RZ402 Publications Data Presentations For Patients Overview Living with HI Living with DME About Our Mission Leadership Board of Directors Scientific Advisory Board Join Us Our Mission Open Positions Benefits Contact Us Investors & Media Overview Corporate Presentation News & Events Stock Quote and Chart Historical Data Analyst Coverage SEC Filings Governance Info --> Elevating the Standard of Care with Transformative Therapies Our Mission Rezolute is a clinical stage biopharmaceutical company dedicated to developing transformative therapies for patients suffering from debilitating metabolic diseases. Ready to Join Us? » Disease Focus Congenital
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 22 Oct 2021 09:01:49 GMT
Server: Apache
Location: http://www.rezolutebio.com/
Content-Type: text/html; charset=UTF-8

HTTP/1.1 302 Moved Temporarily
Content-Type: text/html; charset=UTF-8
Date: Fri, 22 Oct 2021 09:01:49 GMT
Location: https://www.rezolutebio.com/
Server: Apache
Connection: keep-alive

HTTP/1.1 200 OK
Date: Fri, 22 Oct 2021 09:01:49 GMT
Server: Apache
X-Frame-Options: SAMEORIGIN
Content-Type: text/html; charset=UTF-8
rezolutebio.com Whois Information
Domain Name: REZOLUTEBIO.COM
Registry Domain ID: 2176173409_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2019-10-18T14:44:53Z
Creation Date: 2017-10-18T19:10:06Z
Registry Expiry Date: 2021-10-18T19:10:06Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS03.DOMAINCONTROL.COM
Name Server: NS04.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-11T00:31:32Z <<<